Dear Cynata Supporter
I am happy to advise that today SeeThruEquity, LLC has initiated coverage of Cynata Therapeutics Ltd with a 12 month price target of $A 1.55. Please view a copy of the report on Cynata’s website atwww.cynata.com . SeeThruEquity is a US-based equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased.
We are very pleased to note that the SeeThruEquity report recognises the exciting upside potential for Cynata. The report provides a very useful touchstone for the Company in our meetings with US investors next week and we look forward to drawing their attention to the great buying opportunity with CYP at current levels.
Yours sincerely
Ross Macdonald
Dr Ross A Macdonald
Managing Director and Chief Executive Officer
Cynata Therapeutics Ltd
Note unpaid and unbiased.
Dear Cynata Supporter I am happy to advise that today...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $44.01M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.5¢ | $9.043K | 36.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23791 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 12265 | 3 |
View Market Depth
| Last trade - 15.20pm 23/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |